Hep C in
Lucinda K. Porter overviews top studies from one of the world’s largest liver disease research meetings.
Rick Nash, on MELD scores, hospital visits and the ominous taste of popcorn.
A week ago, Matt Starr started on Harvoni hep C treatment. Check out his journey here!
Today, I’m Struggling
Four weeks into HCV treatment, Grace Campbell is disappointed by her latest test results.
The Fear of Letting Go
Now that she’s cured from hepatitis C, Kim Bossley asks: ‘Where do I go from here?’
Detox & Immune Boost
10 health benefits of matcha tea, our new favorite liver-loving drink.
My Anesthesia Hangover
Just days after a liver transplant, Karen Hoyt blogs about her recovery.
The Decision to Try Treatment
Despite the length of therapy, side effects and the cost: it’s worth it, says John Rickman.
EASL 2015 Updates
Check out the latest in hepatitis research from EASL’s 50th International Liver Congress.
Studies show Gilead’s newest triple combo drug works super fast in geno 1’s.
People with hepatitis C have higher cancer rates than others—and it’s not just in the liver.
One More Try?
Merck’s new hepatitis C meds are very effective in treatment-experienced people.
Options for Advanced Cirrhosis
Various combos of Sovaldi, Olysio and ribavirin show promise in patients with liver damage.
Study finds current treatments for alcoholic hepatitis don’t actually extend patients’ lives.
Genotype 3’s Cured
12 weeks of Sovaldi, Interferon and ribavirin cured 93 percent in this hard-to-treat group.
97% Cures for Coinfected
Daclatasvir plus Sovaldi works great in patients with both HIV and hep C.
Your Online Hepatitis Community
Check out what everyone's talking about in the Hep Forums.
Survey finds nearly half of people living with viral hepatitis face some sort of discrimination.
Giving a Liver, Getting a Liver
There’s a major organ shortage in the U.S. right now, but living donors can help save lives.
State HCV Spending Swings
New York spent $297 million on new hep C treatments in 2014. Texas spent nothing.
Free Hep C Treatment
If you live in the country of Georgia, that is. Gilead Sciences announces huge Sovaldi study in Europe.
Research on emerging liver diseases eclipsed hepatitis C at EASL 2015.
Of all the industrialized countries of the world, Japan has the highest rate of hepatitis C.
New saliva test can predict which liver disease patients will experience dangerous ‘flare-ups.’